Scythian Announces Strategic Sale of Latin American and Caribbean Assets in $193,000,000 Deal to Aphria
July 17, 2018 08:34 ET
|
Scythian Biosciences Corp.
Sale of Assets Transforms Scythian Into a Highly Liquid and Well Capitalized Company with Over $200 million in Cash and Marketable Securities on Hand Allows for Additional Transactions in Line with...
Scythian Biosciences Announces Name Change to SOL Global Investments Corp.
June 05, 2018 08:58 ET
|
Scythian Biosciences Corp.
TORONTO, June 05, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that the Company will...
Scythian Biosciences Announces Licensing Agreement With Isodiol International Inc.
May 07, 2018 08:30 ET
|
Scythian Biosciences Corp.
— Scythian Makes $2 Million Investment Alongside Serruya Private Equity, and the Delavaco Group — — Isodiol Recently Awarded the Highly Coveted UK Government Approval for Natural CBD Isolate as an...
Scythian Biosciences Announces Extension of Letter of Intent
May 01, 2018 08:45 ET
|
Scythian Biosciences Corp.
TORONTO, May 01, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSX-V:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) announced today that the Company has signed...
Scythian Announces ABP S.A.’s First Purchase Order with Aphria Inc.
April 18, 2018 09:02 ET
|
Scythian Biosciences Corp.
TORONTO, April 18, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that Argentina-based...
Scythian Biosciences Appoints Gabriel Meneses as Vice President of Latin America and Caribbean
April 17, 2018 08:30 ET
|
Scythian Biosciences Corp.
TORONTO, April 17, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) is pleased to announce the appointments of...
Scythian Biosciences Announces Details of 4-for-1 Stock Split
April 10, 2018 13:19 ET
|
Scythian Biosciences Corp.
TORONTO, April 10, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) is pleased to announce details of the...
Scythian Poised to Enter Argentina Cannabis Market
April 09, 2018 13:48 ET
|
Scythian Biosciences Corp.
ABP S.A., Sets Milestone Receiving Argentina’s First & Only Cannabis License Scythian Sets Pace for Argentina Cannabis Market Through Aphria Partnership and Exclusive Agreements With Country’s...
Scythian Biosciences Corp. Announces Progression of Global Expansion Efforts with Letter of Intent to Acquire MMJ Colombia Partners Inc.
April 09, 2018 09:15 ET
|
Scythian Biosciences Corp.
– Closing of the Acquisition will strengthen Scythian’s Latin American platform with three Colombian cannabis licences including for cultivation of CBD, THC and extraction of cannabis derivatives – –...
Scythian Biosciences Announces Extension of Letter of Intent
March 29, 2018 18:51 ET
|
Scythian Biosciences Corp.
TORONTO, March 29, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) announced today that the Company has signed...